AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2014
Sep 11, 2014
35134_dirs_2014-09-11_0a3a3d89-963a-488d-9048-0472c76441a4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-09-09
Reporting Person: Thompson Tommy G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-09 | Common Stock | M | 2500 | $2.80 | Acquired | 658257 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-09 | Non-qualified stock option | $2.80 | M | 2500 | Acquired | 2022-06-29 | Common Stock (2500) | Indirect |
Footnotes
F1: Owned by Thompson Family Investment, LLC.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16